30 October 2025
Visa Reports Fiscal Fourth Quarter and Full-Year 2025 Results San Francisco, October 28, 2025 – Visa (NYSE: V) Fiscal Fourth Quarter Results: Fiscal Full-Year…
Murray Income Trust PLC (“the Company”) Legal Entity Identifier (LEI): 549300IRNFGVQIQHUI13 30 October 2025 Update on Strategic Review Process The Board of Murray Income…
Quarters $ million Nine months Q3 2025 Q2 2025 Q3 2024 %¹ Reference 2025 2024 % 5,322 3,601 4,291 +48…
Hansa Investment Company Ltd Half-Year Report 30 October 2025 The power of investing differently We are globally diversified, multi-asset class investors who seek to…
29 October 2025
Primary Health Properties PLC (“PHP”, the “Group” or the “Company”) 2025 Annual General Meeting – Voting Results Update Statement At the Company’s Annual General Meeting…
Hargreaves Services plc (“Hargreaves”, the “Company” or the “Group”) AGM Statement and Notice of Interim Results Hargreaves Services plc (AIM: HSP), a diversified group delivering services…
GSK delivers strong Q3 performance and upgrades 2025 guidance Specialty Medicines, Vaccines and General Medicines drive sales, profit and earnings growth (Financial Performance –…
28 October 2025
GSK’s B7-H3-targeted antibody-drug conjugate, GSK’227, receives Orphan Drug Designation in the EU GSK plc (LSE/NYSE: GSK) today announced that GSK5764227 (GSK’227), its B7-H3-targeted antibody-drug conjugate…